These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7014299)

  • 1. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S; Sonne O; Hansen B; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
    Zhou W; Li S; Deng S
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
    Zórad S; Svábová E; Klimes I; Macho L
    Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
    Pérez Maceda B; Linde S; Sonne O; Gliemann J
    Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers.
    Cockram CS; Jones RH; Boroujerdi MA; Sönksen PH
    Diabetes; 1984 Aug; 33(8):721-7. PubMed ID: 6378697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneous mono-(125)i-insulins. Preparation and characterization of mono-(125)i-(tyr a14)-and mono-(125)i-(tyr a19)-insulin.
    Jørgensen KH; Larsen UD
    Diabetologia; 1980; 19(6):546-54. PubMed ID: 7007134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological potency and binding affinity of monoiodoinsulin with iodine in tyrosine A14 or tyrosine A19.
    Gliemann J; Sonne O; Linde S; Hansen B
    Biochem Biophys Res Commun; 1979 Apr; 87(4):1183-90. PubMed ID: 465032
    [No Abstract]   [Full Text] [Related]  

  • 13. A14-125I-monoiodoinsulin purified by high performance liquid chromatography (HPLC): cellular receptor binding properties and long-term stability.
    Benzi L; Marchetti P; Cecchetti P; Pezzino V; Gullo D; Masoni A; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(4):277-81. PubMed ID: 6399077
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
    Linde S; Hansen B
    Int J Pept Protein Res; 1980 May; 15(5):495-502. PubMed ID: 7002822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor binding of biosynthetic human insulin on isolated pig hepatocytes.
    Gammeltoft S
    Diabetes Care; 1981; 4(2):235-7. PubMed ID: 7011734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization].
    Besch W; Woltanski KP; Knospe S; Ziegler M; Keilacker H
    Acta Biol Med Ger; 1980; 39(4):495-502. PubMed ID: 7004036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells.
    Gammeltoft S; Vinten J; Gliemann J; Linde S
    Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [127-I]- or carrier-free [125-I]monoiodoinsulin.
    Sodoyez JC; Sodoyez-Goffaux F; Goff MM; Zimmerman AE; Arquilla ER
    J Biol Chem; 1975 Jun; 250(11):4268-77. PubMed ID: 236316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated degradation of insulin in isolated rat adipocytes. Formation of a degradation product slightly smaller than insulin.
    Sonne O
    Biochim Biophys Acta; 1987 Jan; 927(1):106-11. PubMed ID: 3539208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors.
    Keefer LM; Piron MA; De Meyts P
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1391-5. PubMed ID: 7015337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.